ZUR ROSE GROUP Value Stock - Dividend - Research Selection
Market price: 189,60 CHF
Zur Rose Group AG Fundamental data and company key figures of the share
|Annual reports in CHF|
|Net operating cash flow||-67.511.000|
|Free cash flow||-93.928.000|
|Liabilities & Shareholders equity||1.278.480.000|
|Diluted shares outstanding||9.571.740|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||1.859.047.168,00 USD|
|Indices||STOXX EUROPE 600|
|Raw Data Source||IFRS in Millionen CHF|
Description of the company
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.